Kinnate Biopharma Stock Forecast - Price Action Indicator

KNTEDelisted Stock  USD 2.96  0.27  8.36%   
Kinnate Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Kinnate Biopharma stock prices and determine the direction of Kinnate Biopharma's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Kinnate Biopharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
On July 24, 2023 Kinnate Biopharma had Price Action Indicator of (0.28). Price Action indicator evaluates an asset for a given trading period using the following formula: ((close - open) + (close - high) + (close - low)) / 2. This indicator is consistent with the interpretation of Japanese candlestick patterns.
Check Kinnate Biopharma VolatilityBacktest Kinnate BiopharmaTrend Details  

Kinnate Biopharma Trading Date Momentum

On December 29 2024 Kinnate Biopharma was traded for  2.96  at the closing time. The top price for the day was 3.25  and the lowest listed price was  2.95 . There was no trading activity during the period 0.0. Lack of trading volume on December 29, 2024 did not cause price change. The trading delta at closing time against the current closing price is 9.12% .
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
Compare Kinnate Biopharma to competition

View Kinnate Biopharma Related Equities

 Risk & Return  Correlation

Kinnate Biopharma Market Strength Events

Market strength indicators help investors to evaluate how Kinnate Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kinnate Biopharma shares will generate the highest return on investment. By undertsting and applying Kinnate Biopharma stock market strength indicators, traders can identify Kinnate Biopharma entry and exit signals to maximize returns.

Kinnate Biopharma Risk Indicators

The analysis of Kinnate Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Kinnate Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting kinnate stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Consideration for investing in Kinnate Stock

If you are still planning to invest in Kinnate Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kinnate Biopharma's history and understand the potential risks before investing.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format